-+ 0.00%
-+ 0.00%
-+ 0.00%
Allergy Therapeutics Seeks Cancelation of London Listing
Share
Listen to the news
03:24 AM EST, 11/17/2026 (MT Newswires) -- Allergy Therapeutics (AGY.L) proposed the cancelation of its listing on the London stock exchange's AIM segment and re-registration as a private limited company. The British biotechnology company's plan is subject to the approval of shareholders who own at least 75% of the votes to be cast at its annual general meeting on Dec. 14, according to a Tuesday filing. The board secured verbal commitments from SkyGem and Southern Fox, which together own an 87.98% interest in Allergy Therapeutics, regarding their support of the cancelation and re-registration.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending